Corvus Pharmaceuticals Provides Business Update and Reports
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024 Soquelitinib...
Source: globenewswire.com
Peripheralt Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Peripheralt Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Peripheralt Cell Today - Breaking & Trending Today
From Axatilimab to Zanubrutinib: Treatment Updates Abound
Presentations detail clinical trial results and focus on drugs in the pipeline.
Source: pharmacytimes.com
Our People: Ian Leybas Talks Tribal Affairs, Adversity and Fishing
Our People: Ian Leybas Talks Tribal Affairs, Adversity and Fishing
Source: pr-inside.com
Autolus Therapeutics Presents Positive Results from AUTO4 in Relapsed/Refractory TRBC1-Positive Peripheral T-Cell Lymphoma
At the highest dose 4 out of 4 PTCL patients achieved a response using the original manufacturing process Ongoing complete metabolic responses in 2 out of 4 patients at 15 and 18-months post-dosing at... | June 16, 2023
Source: marketscreener.com
New Manufacturing Process Could Improve CAR T Cell Efficacy Against Aggressive Form of Leukemia
Expert said that manufacturing the T cells with a tyrosine kinase inhibitor may allow more patients to get allogeneic stem cell transplant, the current best means of long-term cure.
Source: pharmacytimes.com